Skip to main content

Find Clinical Trials

Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,318 public trials 177 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

NCT00580125

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Pfizer Investigational Site Garden Grove, California, United States

Pfizer Investigational Site Torrance, California, United States

Pfizer Investigational Site Washington D.C., District of Columbia, United States

Pfizer Investigational Site Detroit, Michigan, United States

View all 26 locations

View Trial Details

Completed

A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults

NCT01429740

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Pfizer Investigational Site New Haven, Connecticut, United States

View Trial Details

Completed

Glycine Treatment of Prodromal Symptoms

NCT00268749

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Not specified

View Trial Details

Completed

The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.

NCT01181934

Conditions: Cognition Disorders, Mental Disorders, Neurocognitive Disorders, +2 more
Locations: Not specified

View Trial Details

Completed

The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients

NCT01186471

Conditions: Cognition Disorders, Mental Disorders, Neurocognitive Disorders, +2 more
Locations: Not specified

View Trial Details

Completed

Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia

NCT00565175

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +11 more
Locations: HUCH Department of Psychiatry Helsinki, Finland

Kellokosken sairaala Kellokoski, Finland

Lohjan sairaanhoitoalue Lohja, Finland

Vaasa Hospital District Vaasa, Finland

View Trial Details

Completed

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

NCT01548612

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: University General Hospital of the Ribeirao Preto Medical School Ribeirão Preto, São Paulo, Brazil

View Trial Details

Completed

Magnetoencephalographic (MEG) Evidence for Novel Metaphor Processing Among Schizophrenic Patients

NCT01325363

Conditions: Mental Disorders, Novel Metaphor, Schizophrenia, +1 more
Locations: shalvata MHC Hod HaSharon, Israel

View Trial Details

Completed

A Study of Olanzapine in Patients With Schizophrenia

NCT00970281

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gunma, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan

View Trial Details

Completed

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

NCT00097942

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Synergy Clinical Research National City, California, United States

VA San Diego Healthcare System San Diego, California, United States

University of Miami Jackson Memorial Hospital Miami, Florida, United States

University of Iowa Psychiatric Research Iowa City, Iowa, United States

View all 13 locations

View Trial Details